Predict your next investment

SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
heartflow.com

See what CB Insights has to offer

Total Raised

$542.41M

Investors Count

13

Deal Terms

10

HeartFlow Funding, HeartFlow Valuation & HeartFlow Revenue

14 Fundings

HeartFlow's latest funding round was a Acq - Pending for on July 15, 2021.

HeartFlow's valuation in February 2018 was $1,500M.

HeartFlow's latest post-money valuation is from July 2021.

Sign up for a free trial to see HeartFlow's valuations in July 2021, December 2017, May 2016 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/15/2021

Acq - Pending

$99M

1

6/14/2019

Series F

$65M

1

2/14/2018

Series E - II

$150M

Baillie Gifford & Co., Undisclosed Investors, and Wellington Management

$1,500M

5

12/4/2017

Series E

$99M

$99M

10

5/20/2016

Series D - II

$99M

$99M

10

Date

7/15/2021

6/14/2019

2/14/2018

12/4/2017

5/20/2016

Round

Acq - Pending

Series F

Series E - II

Series E

Series D - II

Amount

$65M

$150M

$99M

$99M

Investors

Baillie Gifford & Co., Undisclosed Investors, and Wellington Management

Valuation

$99M

$1,500M

$99M

$99M

Revenue

Sources

1

1

5

10

10

HeartFlow Deal Terms

10 Deal Terms

HeartFlow's deal structure is available for 10 funding rounds, including their Acq - Pending from July 15, 2021.

Round

Acq - Pending

Series E - II

Series E

Series D - II

Series D

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

$99M

$99M

Post-Money Valuation

$99M

$99M

$99M

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acq - Pending

$99M

$99M

$99M

$99M

Series E - II

$99M

$99M

$99M

$99M

$99M

$99M

Series E

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series D - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series D

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

HeartFlow Investors

13 Investors

HeartFlow has 13 investors. Longview Acquisition invested in HeartFlow's Acq - Pending funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/15/2021

7/15/2021

1
Acq - Pending

SPAC

New York

2/11/2011

6/14/2019

6
Series B, Series C (2014), Series D (2015), Series D - II (2016), Series E (2017), Series F (2019)

Venture Capital

California

2/14/2018

2/14/2018

1
Series E - II

Asset/Investment Management

Massachusetts

00/00/0000

00/00/0000

Baillie Gifford & Co.

Subscribe to see more

Asset/Investment Management

United Kingdom

00/00/0000

00/00/0000

HealthCor Management

Subscribe to see more

Subscribe to see more

Private Equity

New York

First funding

7/15/2021

2/11/2011

2/14/2018

00/00/0000

00/00/0000

Last Funding

7/15/2021

6/14/2019

2/14/2018

00/00/0000

00/00/0000

Investor

Baillie Gifford & Co.

HealthCor Management

Rounds

1
Acq - Pending
6
Series B, Series C (2014), Series D (2015), Series D - II (2016), Series E (2017), Series F (2019)
1
Series E - II

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

SPAC

Venture Capital

Asset/Investment Management

Asset/Investment Management

Private Equity

Location

New York

California

Massachusetts

United Kingdom

New York

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.